.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Chinese Patent Office
QuintilesIMS
Dow
Express Scripts
Medtronic
Novartis
Chubb
Fish and Richardson

Generated: November 23, 2017

DrugPatentWatch Database Preview

Temazepam - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for temazepam and what is the scope of temazepam freedom to operate?

Temazepam
is the generic ingredient in three branded drugs marketed by Duramed Pharms Barr, Actavis Elizabeth, Mylan, Sandoz, Watson Labs, Quantum Pharmics, Novel Labs Inc, Mallinckrodt Inc, Sun Pharm Inds, Prinston Inc, Amneal Pharms, and Usl Pharma, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for temazepam. Forty suppliers are listed for this compound.

Pharmacology for temazepam

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine

Medical Subject Heading (MeSH) Categories for temazepam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
TEMAZEPAM
temazepam
CAPSULE;ORAL071446-001May 21, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Usl Pharma
TEMAZEPAM
temazepam
CAPSULE;ORAL070490-001Jul 7, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Prinston Inc
TEMAZEPAM
temazepam
CAPSULE;ORAL201781-004Jun 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Prinston Inc
TEMAZEPAM
temazepam
CAPSULE;ORAL201781-003Jun 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Prinston Inc
TEMAZEPAM
temazepam
CAPSULE;ORAL201781-002Jun 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
TEMAZEPAM
temazepam
CAPSULE;ORAL071457-001Apr 21, 1987ABRXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt Inc
RESTORIL
temazepam
CAPSULE;ORAL018163-003Oct 25, 1991ABRXYesNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
TEMAZEPAM
temazepam
CAPSULE;ORAL071620-001Aug 7, 1987ABRXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
TEMAZEPAM
temazepam
CAPSULE;ORAL071457-003Jun 22, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
TEMAZEPAM
temazepam
CAPSULE;ORAL078581-001Sep 8, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: temazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mallinckrodt Inc
RESTORIL
temazepam
CAPSULE;ORAL018163-003Oct 25, 1991► Subscribe► Subscribe
Mallinckrodt Inc
RESTORIL
temazepam
CAPSULE;ORAL018163-003Oct 25, 1991► Subscribe► Subscribe
Mallinckrodt Inc
RESTORIL
temazepam
CAPSULE;ORAL018163-003Oct 25, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
QuintilesIMS
Healthtrust
Citi
McKesson
Dow
Novartis
Johnson and Johnson
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot